BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10394511)

  • 1. [Microinvasive ductal carcinoma of the breast. Role of axillary lymph node dissection].
    Le Bouëdec G; Penault-Llorca F; de Latour M; Joubert J; Kauffmann P; Pomel C; Dauplat J
    J Gynecol Obstet Biol Reprod (Paris); 1999 Feb; 28(1):10-6. PubMed ID: 10394511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience.
    Padmore RF; Fowble B; Hoffman J; Rosser C; Hanlon A; Patchefsky AS
    Cancer; 2000 Mar; 88(6):1403-9. PubMed ID: 10717623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy.
    Tunon-de-Lara C; Giard S; Buttarelli M; Blanchot J; Classe JM; Baron M; Monnier B; Houvenaeghel G
    Breast J; 2008; 14(2):135-40. PubMed ID: 18315691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
    Meijnen P; Oldenburg HS; Loo CE; Nieweg OE; Peterse JL; Rutgers EJ
    Br J Surg; 2007 Aug; 94(8):952-6. PubMed ID: 17440955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature.
    Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E
    Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is complete axillary lymph node dissection neccessary in T1 stage invasive pure tubular carcinomas of the breast?
    Fernández-Aguilar S; Simon P; Buxant F; Fayt I; Nöel JC
    Breast; 2005 Aug; 14(4):325-8. PubMed ID: 16085240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular dyscohesion in fine-needle aspiration of breast carcinoma. Prognostic indicator for axillary lymph node metastases?
    Schiller AB; Tadros TS; Birdsong GG; Grossl NA
    Am J Clin Pathol; 2001 Feb; 115(2):219-23. PubMed ID: 11211610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of sentinel lymph node biopsy in breast ductal carcinoma in situ upstaged to invasive carcinoma.
    Sakr R; Antoine M; Barranger E; Dubernard G; Salem C; Daraï E; Uzan S
    Breast J; 2008; 14(1):55-60. PubMed ID: 18186866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ductal carcinoma in situ of the breast with microinvasion. Role of sentinel lymph node biopsy].
    Le Bouëdec G; de Lapasse C; Mishellany F; Chêne G; Michy T; Gimbergues P; Dauplat J
    Gynecol Obstet Fertil; 2007 Apr; 35(4):317-22. PubMed ID: 17344087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is axillary lymph node dissection necessary in elderly patients with breast carcinoma who have a clinically uninvolved axilla?
    Martelli G; Miceli R; De Palo G; Coradini D; Salvadori B; Zucali R; Galante E; Marubini E
    Cancer; 2003 Mar; 97(5):1156-63. PubMed ID: 12599220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Observations on the histopathologic diagnosis of microinvasive carcinoma of the breast.
    Prasad ML; Osborne MP; Hoda SA
    Anat Pathol; 1998; 3():209-32. PubMed ID: 10389587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor size as predictor of microinvasion, invasion, and axillary metastasis in ductal carcinoma in situ.
    Maffuz A; Barroso-Bravo S; Nájera I; Zarco G; Alvarado-Cabrero I; Rodríguez-Cuevas SA
    J Exp Clin Cancer Res; 2006 Jun; 25(2):223-7. PubMed ID: 16918134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
    Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
    J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microinvasive breast cancer and the role of sentinel node biopsy: an institutional experience and review of the literature.
    Guth AA; Mercado C; Roses DF; Darvishian F; Singh B; Cangiarella JF
    Breast J; 2008; 14(4):335-9. PubMed ID: 18537917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
    Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
    J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis.
    Joseph KA; El-Tamer M; Komenaka I; Troxel A; Ditkoff BA; Schnabel F
    Arch Surg; 2004 Jun; 139(6):648-51. PubMed ID: 15197092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment analysis of 26 patients with breast ductal carcinoma in situ].
    Zhang LB; Xu YX; Geng JL; Zhang YH
    Zhonghua Zhong Liu Za Zhi; 2003 Mar; 25(2):195-7. PubMed ID: 12795854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axillary dissection can be avoided in selected breast cancer patients: analysis of 401 cases.
    Greco M; Agresti R; Raselli R; Giovanazzi R; Veronesi U
    Anticancer Res; 1996; 16(6C):3913-7. PubMed ID: 9042312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.